ES2053989T3 - Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada. - Google Patents

Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada.

Info

Publication number
ES2053989T3
ES2053989T3 ES89305209T ES89305209T ES2053989T3 ES 2053989 T3 ES2053989 T3 ES 2053989T3 ES 89305209 T ES89305209 T ES 89305209T ES 89305209 T ES89305209 T ES 89305209T ES 2053989 T3 ES2053989 T3 ES 2053989T3
Authority
ES
Spain
Prior art keywords
dosage form
solid
controlled release
oral dosage
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89305209T
Other languages
English (en)
Inventor
Joanne Heafield
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Philip John Neale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of ES2053989T3 publication Critical patent/ES2053989T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A UNA DOSIFICACION ORAL SOLIDA, DE LIBERACION CONTROLADA, QUE CONTIENE UNA 3 - ALQUIL - XANTINA, PREFERIBLEMENTE TEOFILINA, POR LO MENOS UN POLIMERO HIDROFILICO O HIDROFOBICO, AL MENOS UNA CERA CON UN PUNTO DE FUSION ENTRE 25 Y 90 (GRADOS) C Y ENTRE UN 3 Y UN 10% (EN PESO) DE AGUA. PREFERIBLEMENTE LA FORMA DE DOSIFICACION ES UN COMPRIMIDO CON UN CONTENIDO DE AGUA ENTRE 4 Y 9% LA CANTIDAD DE AGUA PRESENTE EN LA FORMA DE DOSIFICACION, DETERMINA LA VELOCIDAD DE LIBERACION DE LA 3 ALQUILXANTINA.
ES89305209T 1988-06-02 1989-05-23 Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada. Expired - Lifetime ES2053989T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content

Publications (1)

Publication Number Publication Date
ES2053989T3 true ES2053989T3 (es) 1994-08-01

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89305209T Expired - Lifetime ES2053989T3 (es) 1988-06-02 1989-05-23 Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada.

Country Status (19)

Country Link
US (1) US5091189A (es)
EP (1) EP0344960B1 (es)
JP (1) JPH0816060B2 (es)
KR (1) KR0136279B1 (es)
AT (1) ATE83925T1 (es)
AU (1) AU610401B2 (es)
CA (1) CA1323834C (es)
DE (1) DE68904119T2 (es)
DK (1) DK175130B1 (es)
ES (1) ES2053989T3 (es)
FI (1) FI93695C (es)
GB (2) GB8813064D0 (es)
GR (1) GR3007088T3 (es)
IE (1) IE61998B1 (es)
IL (1) IL90462A (es)
NO (1) NO176232C (es)
NZ (1) NZ229372A (es)
PT (1) PT90722B (es)
ZA (1) ZA894201B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
EP1041988A4 (en) * 1997-12-22 2002-03-13 Euro Celtique Sa METHOD FOR PREVENTING ABUSE OF OPIOID DOSES FORMS
EP1041987B1 (en) 1997-12-22 2006-04-19 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
EP2092936B1 (en) 2000-02-08 2013-03-20 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
SI1416842T1 (sl) * 2001-07-18 2009-06-30 Euro Celtique Sa Farmacevtske kombinacije oksikodona in naloksona
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
IL160222A0 (en) 2001-08-06 2004-07-25 Euro Celtique Sa Opioid agonist formulations with releasable and sequestered antagonist
IN192180B (es) * 2001-09-28 2004-03-06 Ranbaxy Lab
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
HUE032656T2 (en) 2002-04-05 2017-10-30 Euro Celtique Sa Pharmaceutical composition containing oxicodone and naloxone
CN1703200B (zh) * 2002-09-20 2012-02-29 奥尔制药公司 隔离亚单元和相关组合物及方法
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
EP1592453A1 (en) * 2003-01-28 2005-11-09 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
ATE415148T1 (de) * 2004-10-19 2008-12-15 Krka Tovarna Zdravil D D Novo Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US20080248107A1 (en) * 2005-08-24 2008-10-09 Rubicon Research Pvt. Ltd. Controlled Release Formulation
SI2719378T1 (sl) * 2006-06-19 2016-11-30 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
CA2662358C (en) * 2006-09-29 2015-02-10 The Procter & Gamble Company Oral compositions containing gel networks
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
AU2008346870A1 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
EP2317991B1 (en) * 2008-07-07 2017-05-03 Euro-Celtique S.A. Use of opioid antagonists for treating urinary retention
SG174286A1 (en) 2009-03-10 2011-10-28 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
JP2016525138A (ja) 2013-07-23 2016-08-22 ユーロ−セルティーク エス．エイ． 疼痛および腸内ディスバイオシスをもたらす疾患および／または腸内細菌移行に対するリスクを高める疾患に罹患している患者における痛みの治療への使用のためのオキシコドンおよびナロキソンの組み合わせ
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
JPH0816060B2 (ja) 1996-02-21
IL90462A0 (en) 1990-01-18
DK266889D0 (da) 1989-06-01
IL90462A (en) 1993-01-31
DE68904119D1 (de) 1993-02-11
AU610401B2 (en) 1991-05-16
DK175130B1 (da) 2004-06-14
ZA894201B (en) 1990-03-28
IE61998B1 (en) 1994-12-14
GB8911629D0 (en) 1989-07-05
EP0344960A2 (en) 1989-12-06
EP0344960A3 (en) 1990-03-07
GB2219207B (en) 1992-01-02
FI892664L (fi) 1989-12-03
IE891744L (en) 1989-12-02
NO892229L (no) 1989-12-04
FI93695C (fi) 1995-05-26
JPH0225420A (ja) 1990-01-26
NO892229D0 (no) 1989-06-01
NZ229372A (en) 1991-07-26
KR900000077A (ko) 1990-01-30
PT90722B (pt) 1994-11-30
NO176232C (no) 1995-03-01
KR0136279B1 (ko) 1998-04-25
CA1323834C (en) 1993-11-02
DE68904119T2 (de) 1993-06-09
GB2219207A (en) 1989-12-06
PT90722A (pt) 1989-12-29
NO176232B (no) 1994-11-21
EP0344960B1 (en) 1992-12-30
FI892664A0 (fi) 1989-06-01
DK266889A (da) 1989-12-03
AU3512789A (en) 1989-12-07
GB8813064D0 (en) 1988-07-06
US5091189A (en) 1992-02-25
ATE83925T1 (de) 1993-01-15
FI93695B (fi) 1995-02-15
GR3007088T3 (es) 1993-07-30

Similar Documents

Publication Publication Date Title
ES2053989T3 (es) Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada.
LV5503A3 (lv) Panemiens omeprazola salu iegusanai
ES2053567T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica de liberacion controlada.
BE1002159A5 (fr) Adsorbats medicamenteux.
ES2027005T3 (es) Procedimiento para preparar una formulacion farmaceutica de liberacion controlada de acrivastina.
ITBS920092A0 (it) Composizione per la liberazione prolungata e controllata di una sostanza medicamentosa peptica e procedimento per la sua preparazione
KR0141473B1 (en) Dispensing device
BE901359A (fr) Composition pharmaceutique a absorption reglee.
ES8403316A1 (es) Un procedimiento para la preparacion de una composicion a base de sales de cinc y sales de fluoruro.
ES2044156T3 (es) Jabon transparente que contiene un 1,2-alcanodiol.
ATE49347T1 (de) Arzneiformen zur oralen verabreichung.
IT1178511B (it) Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
ATE66784T1 (de) Nahrungsgemisch fuer alte menschen.
JPS57118511A (en) Gradually releasing preparation
DE3850659D1 (de) Zahnfüllungsmaterial.
PT97842A (pt) Processo para a preparacao de composicoes farmaceuticas e/ou cosmeticas,sob a forma de pelicula, contendo pelo menos um alcool polivinilico soluvel na agua, pelo menos um agente tensioactivo e pelo menos uma substancia vegetal com accao farmaceutica e/ou cosmetica
GT197640950A (es) Composiciones de oxitetraciclina y su preparacion.
NO157963C (no) Tannpleiemidler som inneholder funksjonelle, agglomererte, spettede partikler.
CU21980A1 (es) Composicion mineralizante dental y su forma farmaceutica
YU70804A (sh) Oksikodonski derivati koji se kontrolisano ispuštaju
GT198500045A (es) Una composicion para la higiene oral
MX172016B (es) Composicion de cemento dental de fosfato de zinc y proceso para su preparacion
GT198167247A (es) Mejoras a composicion de crema dental
IT1223097B (it) Formulazione farmaceutica contenente gemfibrozil microincapsulato

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 344960

Country of ref document: ES